US Health Authorities, Vaccine Makers Planning Monovalent COVID-19 Booster, Next Boosters Will Target An XBB Variant
Portfolio Pulse from Bill Haddad
US health authorities and vaccine makers are planning a monovalent COVID-19 booster, with future boosters targeting the XBB variant. Companies involved include AZN, BNTX, JNJ, MRNA, NVAX, and PFE.
May 26, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AstraZeneca is involved in the development of a monovalent COVID-19 booster and future boosters targeting the XBB variant.
As AstraZeneca is one of the companies mentioned in the development of the monovalent COVID-19 booster and future boosters targeting the XBB variant, it is likely to have a positive impact on their stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
BioNTech is involved in the development of a monovalent COVID-19 booster and future boosters targeting the XBB variant.
As BioNTech is one of the companies mentioned in the development of the monovalent COVID-19 booster and future boosters targeting the XBB variant, it is likely to have a positive impact on their stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Johnson & Johnson is involved in the development of a monovalent COVID-19 booster and future boosters targeting the XBB variant.
As Johnson & Johnson is one of the companies mentioned in the development of the monovalent COVID-19 booster and future boosters targeting the XBB variant, it is likely to have a positive impact on their stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Moderna is involved in the development of a monovalent COVID-19 booster and future boosters targeting the XBB variant.
As Moderna is one of the companies mentioned in the development of the monovalent COVID-19 booster and future boosters targeting the XBB variant, it is likely to have a positive impact on their stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Novavax is involved in the development of a monovalent COVID-19 booster and future boosters targeting the XBB variant.
As Novavax is one of the companies mentioned in the development of the monovalent COVID-19 booster and future boosters targeting the XBB variant, it is likely to have a positive impact on their stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Pfizer is involved in the development of a monovalent COVID-19 booster and future boosters targeting the XBB variant.
As Pfizer is one of the companies mentioned in the development of the monovalent COVID-19 booster and future boosters targeting the XBB variant, it is likely to have a positive impact on their stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100